# Derek Manzoni, Founder at Manzoni Growth Partners — read of Healthcare Vendor Prospect Feed, June 10 2026 > 14 years in healthcare B2B, ran inside sales at a DME distributor for six years before going independent. Now I run a 6-person agency that does sales enablement and outsourced SDR work for small healthtech vendors. Drive my 9-year-old to hockey Tuesday and Thursday mornings. I'm probably looking at this during the drive home. --- ## How I got here I'm in the Sales Connector ecosystem. Got a note in the newsletter or somewhere in the user community that Wishdeal was publishing business idea kits for SC operators. I typed the URL directly. I was curious whether this was a white-label data product I could layer on top of what I already sell my clients. That's my frame the whole time I'm reading. --- ## What I clicked first The headline is doing real work: "Weekly Prospect Lists for B2B Healthcare Vendors." I know what that is. I have clients who pay Apollo and ZoomInfo and still complain the lists are garbage. The sub-claims under "Enriched Contact Records" are specific in the right way: "verified mobile, email, facility name, bed count, EHR system, and decision-maker titles." That's not a generic bullet list. Someone who knows this space wrote that. Bed count and EHR system are things my clients actually care about. That line kept me reading. --- ## Where I paused The Fermi math section. Not because it's bad. Because I've never seen a product page do this. "$-16,495 Year-1 take-home" is a number that should scare most people off, and they put it right there. Same with "1 in 8 Meaningful-success odds." I sat with that for a minute. Either this is the most honest product page I've seen this year, or it's a very clever way to disqualify anyone who isn't already committed. I'm still not sure which. The fact that "financial upside: 2/10" is listed as a concern you should know about, alongside "buyer clarity: 10/10" and "distribution ease: 10/10" -- that's a strange combination to publish. It's basically saying: "The idea is easy to sell, easy to build a customer for, but you probably won't make much money." Okay. I respect that but I need to understand the gap. --- ## What I distrusted "No guessing." Full stop. That's the kind of claim that only lands if you show me an example record. Show me a blinded sample row. Show me what the mobile verify rate actually is. ZoomInfo says "verified" too and my clients hit 40% bounce rates on mobile. The claim is in the right place but there's nothing behind it. Also: "Real-time Clinic Signals." The copy says "hiring clinical staff, expanding facilities, or acquiring new locations." I want to know exactly where those signals come from. Job boards? State licensing filings? Press releases? That sourcing question is the whole product. If the answer is job board scraping, this competes with half of LinkedIn's features. If it's state licensing data plus acquisitions filings, that's genuinely differentiated. The page doesn't say. The SOC 2 Type II badge is interesting on a page that also says "we don't have live customers on this idea yet." SOC 2 for what, exactly? The idea kit? That felt like a platform boilerplate badge that migrated to this page without anyone checking. --- ## What would convince me One blinded sample prospect record. Mask the clinic name if you want. But show me the actual fields: what the EHR field looks like, what the "decision-maker titles" field looks like, whether it's one name or a list, whether mobile is a direct line or a main number. That single thing would tell me more than all the bullets. After that, I want to see one operator (doesn't need a logo, can be anonymous) who has run this for even 60 days and can say what their connect rate was versus their baseline. Not a revenue number. Just: "We called 200 of these, here's what happened." --- ## What I'd ask in an email reply 1. The signal sourcing question: where specifically does the "hiring clinical staff" or "acquiring new locations" data come from? Is this scraped, licensed, or something you're doing manually at this scale? 2. The gap between buyer clarity 10/10 and financial upside 2/10 is bugging me. Is the ceiling low because of the data licensing costs eating margin, because of list commoditization, or because you see market saturation? I want to know which problem I'd be walking into. 3. If I adopt this through my SC tenant and white-label it to three of my current agency clients as a monthly add-on, what's the realistic unit economics look like? The Fermi math is for a standalone operator. I'm not that. --- ## Verdict: curious-enough-to-reply The honest scoring flipped me from skeptical to interested. I've seen enough vague "10X your pipeline" pages that a page willing to publish a negative Year-1 number and a 2/10 financial upside gets my attention. I have enough context in this space to know the claims are in the right neighborhood. I'd send one email before I spent 20 minutes on the $5 dossier. --- *Memo by skeptic persona, generated 2026-06-10. Studio breaks own self-grading loop.*